Suchergebnisse - "Gottlieb, Robert L."

PubPharm (12)

1

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials

enthalten in: Viruses | 2024

von Hedskog, C. | Spinner, C. | Protzer, U. | +24

2

Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19

enthalten in: The Lancet. Infectious diseases | 2024

von Gottlieb, R. | Paredes, R.

3

Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves : Findings From Routine Clinical Practice

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Mozaffari, E. | Chandak, A. | Gottlieb, R. | +8

4

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial

enthalten in: Annals of internal medicine | 2022

von ACTIV-3/TICO Bamlanivimab Study Group | Lundgren, J. | Grund, B. | +151

5

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

enthalten in: The New England journal of medicine | 2022

von Gottlieb, R. | Vaca, C. | Paredes, R. | +128

CommentIn: N Engl J Med. 2022 Jan 27;386(4):385-387. - PMID 34936760

6

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Olender, S. | Perez, K. | Go, A. | +31

CommentIn: Clin Infect Dis. 2021 Dec 6;73(11):e4175-e4178. - PMID 32735655

7

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia : a randomized clinical trial

enthalten in: Intensive care medicine | 2021

von Rosas, I. | Diaz, G. | Gottlieb, R. | +18

8

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

enthalten in: The New England journal of medicine | 2021

von ACTIV-3/TICO LY-CoV555 Study Group | Lundgren, J. | Grund, B. | +144

CommentIn: N Engl J Med. 2021 Feb 3;:. - PMID 33534967

9

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 : A Randomized Clinical Trial

enthalten in: JAMA | 2021

von Gottlieb, R. | Nirula, A. | Chen, P. | +24

CommentIn: JAMA. 2021 Feb 16;325(7):644-645. - PMID 33475716

10

Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together

enthalten in: Frontiers in immunology | 2021

von Zhang, L. | Poorbaugh, J. | Dougan, M. | +14